Time to recurrence · transurethral resection of bladder tumors in people with suspected or diagnosed non‐muscle invasive bladder cancer
NBI + WLC TURBT may leads to lower time to disease recurrence compared with WLC TURBT (low certainty).
1 finding from 1 review
Time to progression · transurethral resection of bladder tumors in people with suspected or diagnosed non‐muscle invasive bladder cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clavien‐Dindo grade ≥ 3 complications · transurethral resection of bladder tumors in people with suspected or diagnosed non‐muscle invasive bladder cancer
NBI + WLC TURBT showed no clear difference in major adverse event (Clavien‐Dindo grade III, IV, and V) compared with WLC TURBT (low certainty).
1 finding from 1 review
Time to death from bladder cancer · transurethral resection of bladder tumors in people with suspected or diagnosed non‐muscle invasive bladder cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clavien‐Dindo grade ≤ 2 complications8 · transurethral resection of bladder tumors in people with suspected or diagnosed non‐muscle invasive bladder cancer
NBI + WLC TURBT showed no clear difference in minor adverse event (Clavien‐Dindo grade I and II) compared with WLC TURBT (low certainty).
1 finding from 1 review
Urologic symptom scores · men with lower urinary tract symptoms secondary to benign prostatic obstruction
1 finding from 1 review
Retreatment Participants requiring additional procedures or surgery · men with lower urinary tract symptoms secondary to benign prostatic obstruction
Transurethral microwave thermotherapy may leads to lower retreatment Participants requiring additional procedures or surgery compared with sham treatment (low certainty).
1 finding from 1 review
Erectile function · men with lower urinary tract symptoms secondary to benign prostatic obstruction
1 finding from 1 review
Ejaculatory function · men with lower urinary tract symptoms secondary to benign prostatic obstruction
1 finding from 1 review
Quality of life · men with lower urinary tract symptoms secondary to benign prostatic obstruction
1 finding from 1 review
Major adverse events · men with lower urinary tract symptoms secondary to benign prostatic obstruction
Transurethral microwave thermotherapy probably leads to lower major adverse events compared with transurethral resection of the prostate (moderate certainty).
1 finding from 1 review
Retreatment Participants requiring additional procedures or surgery · men with lower urinary tract symptoms secondary to benign prostatic obstruction
Transurethral microwave thermotherapy probably leads to higher retreatment Participants requiring additional procedures or surgery compared with transurethral resection of the prostate (moderate certainty).
1 finding from 1 review
Erectile function · men with lower urinary tract symptoms secondary to benign prostatic obstruction
Transurethral microwave thermotherapy showed no clear difference in erectile function (sexually‐active men only) compared with transurethral resection of the prostate (low certainty).
1 finding from 1 review
Ejaculatory function · men with lower urinary tract symptoms secondary to benign prostatic obstruction
Transurethral microwave thermotherapy may leads to lower ejaculatory function (sexually‐active men only) compared with transurethral resection of the prostate (low certainty).
1 finding from 1 review
Urologic symptom scores · men with lower urinary tract symptoms secondary to benign prostatic obstruction
1 finding from 1 review
Quality of life · men with lower urinary tract symptoms secondary to benign prostatic obstruction
1 finding from 1 review
Major adverse events · men with lower urinary tract symptoms secondary to benign prostatic obstruction
1 finding from 1 review
Time to recurrence · patients with non‐muscle invasive bladder cancer
Gemcitabine showed no clear difference in time to recurrence (absolute effect size estimates based on… compared with saline (low certainty).
1 finding from 1 review
Grade III–V adverse events (local adverse events which result in delay intravesical treatment were regarded as Grade III–V complications) · patients with non‐muscle invasive bladder cancer
It is very uncertain whether gemcitabine changes grade III–V adverse events (local adverse events which result in… compared with mitomycin (very low certainty).
1 finding from 1 review
Time to death from bladder cancer · patients with non‐muscle invasive bladder cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found